Caricamento...
In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers
INTRODUCTION: We have used positron emission tomography (PET) to assess dopaminergic and serotonergic terminal density in three subjects carrying a mutation in the DCT1 gene, two clinically affected with Perry syndrome. METHODS: All subjects had brain imaging using 18F-6-fluoro-L-dopa (FDOPA, dopami...
Salvato in:
| Autori principali: | , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4139463/ https://ncbi.nlm.nih.gov/pubmed/24797316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25893 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|